Editorial
doi: 10.1016/j.amjmed.2004.03.008.
Aspirin or clopidogrel for secondary prevention of cardiovascular events: is there a winner?
- PMID: 15178502
- DOI: 10.1016/j.amjmed.2004.03.008
Item in Clipboard
Editorial
Aspirin or clopidogrel for secondary prevention of cardiovascular events: is there a winner?
Am J Med.
.
No abstract available
Comment on
-
Clopidogrel versus aspirin for secondary prophylaxis of vascular events: a cost-effectiveness analysis.Am J Med. 2004 Jun 15;116(12):797-806. doi: 10.1016/j.amjmed.2004.01.014. Am J Med. 2004. PMID: 15178495
Similar articles
-
Clopidogrel and [symbol: see text] ticlopidine--improvements on aspirin?Drug Ther Bull. 1999 Aug;37(8):59-61. Drug Ther Bull. 1999. PMID: 10696686 Review.
-
Recent developments in the use of antiplatelet agents to prevent cardiovascular events.Future Cardiol. 2011 May;7(3):403-13. doi: 10.2217/fca.11.8. Future Cardiol. 2011. PMID: 21627479 Review.
-
Aspirin, ticlopidine and clopidogrel in and out of the catheterization laboratory.J Invasive Cardiol. 1999 Jun;11 Suppl A:20A-29A. J Invasive Cardiol. 1999. PMID: 10745607 Review. No abstract available.
-
Clopidogrel for the prevention of atherothrombotic events.N Engl J Med. 2006 Jul 27;355(4):420; author reply 420-1. N Engl J Med. 2006. PMID: 16871689 No abstract available.
-
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction.N Engl J Med. 2005 Jun 23;352(25):2647-8; author reply 2647-8. doi: 10.1056/NEJM200506233522518. N Engl J Med. 2005. PMID: 15972875 No abstract available.
Cited by
-
Revaluation of clopidogrel: let the data speak for themselves.J Huazhong Univ Sci Technolog Med Sci. 2010 Jun;30(3):299-306. doi: 10.1007/s11596-010-0346-3. Epub 2010 Jun 17. J Huazhong Univ Sci Technolog Med Sci. 2010. PMID: 20556571
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
